title: The interaction of plasma renin activity and plasma atrial natriuretic peptide in 21-hydroxylase deficiency patients.
abstract: Plasma renin activity (PRA) determination is the main index used to evaluate the mineralocorticoid control in 21-hydroxylase deficiency (21-OHD). PRA values within or at the upper limit of the age-appropriate range, or values <5 or 10 ng/ml/h have been regarded as adequate control. Atrial natriuretic peptide (ANP) has opposite actions to those of angiotensin II/aldosterone, and could help to understand the hydrosaline homeostasis in 21-OHD. We studied the interaction between PRA and ANP levels in 10 controls and 26 patients with 21-OHD under corticoid treatment. Patients were divided into two groups according to PRA levels, < or > or = 5 ng/ml/h, irrespective of the clinical form of 21-OHD. Blood samples for determination of PRA and ANP levels were taken after 30 min in the sitting position (basal), after 30 min in the recumbent position and after 15 min of 20 degrees head-down tilting. ANP levels (pg/ml) in the basal, supine and after head-down tilting position were 25.9 +/- 1.6, 42.7 +/- 7.4 and 54.3 +/- 5.5 in controls; 28.5 +/- 2.1, 38.3 +/- 2.1 and 48.8 +/- 4.1 in the group with PRA levels <5 ng/ml/h, and 20.9 +/- 1.9, 26.6 +/- 2.5 and 34.6 +/- 3.1 in the group with PRA levels > or = 5 ng/ml/h, respectively. Basal and after head-down tilting ANP plasma levels were similar between the controls and the group with PRA levels <5 ng/ml/h. However, the group of patients with PRA levels > or = 5 ng/ml/h showed lower basal and stimulated ANP levels compared to the control group (p<0.05). The decreased plasma ANP levels in the basal condition and after head-down tilting indicate a chronic contraction of the extracellular volume in 21-OHD patients with increased PRA levels. Therefore, mineralocorticoid deficiency is counteracted by decreased ANP secretion in order to preserve fluid and electrolyte homeostasis.
authors.affiliation: Division of Endocrinology, Department of Internal Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, SP, Brazil.
authors.forename: C M R
authors.initials: CM
authors.lastname: Germano
authors.forename: M
authors.initials: M
authors.lastname: de Castro
authors.forename: J C
authors.initials: JC
authors.lastname: Crescencio
authors.forename: L
authors.initials: L
authors.lastname: Gallo
authors.forename: J
authors.initials: J
authors.lastname: Antunes-Rodrigues
authors.forename: A C
authors.initials: AC
authors.lastname: Moreira
authors.forename: L L K
authors.initials: LL
authors.lastname: Elias
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000312:Adrenal Hyperplasia, Congenital / Q000503:physiopathology*; D000328:Adult; D009320:Atrial Natriuretic Factor / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D011187:Posture; D012016:Reference Values; D012083:Renin / Q000502:physiology*; D013255:Steroid 21-Hydroxylase
chemical_list: D000305:Adrenal Cortex Hormones; D009320:Atrial Natriuretic Factor; D013255:Steroid 21-Hydroxylase; D012083:Renin